About John M. Kane III

Dr. John M. Kane III is the Chair of Surgical Oncology and Chief of the Melanoma/Sarcoma service at Roswell Park Comprehensive Cancer Center. He has been in practice since 2000 and specializes in the treatment of soft tissue sarcomas and melanoma. He is a member of major sarcoma groups including the National Comprehensive Cancer Network Sarcoma Panel (Vice Chair), the Connective Tissue Oncology Society, and the Society of Surgical Oncology Sarcoma Disease Site Working Group (Vice Chair).

He has been the lead investigator for several sarcoma trials at Roswell Park, authored multiple papers on the treatment of soft tissue sarcomas and has been an invited speaker on this topic at national meetings. He oversees the weekly sarcoma/soft tissue tumor multidisciplinary conference where all new sarcoma and rare soft tissue tumor cases are discussed to develop the optimal treatment plan.

He also has a significant clinical interest in melanoma and other aggressive cutaneous malignancies such as Merkel cell carcinoma. He has advanced the regional therapies program at Roswell Park for patients with isolated extremity disease and developed the cytoreduction/hyperthermic intraperitoneal chemoperfusion (HIPEC) program at Roswell Park Comprehensive Cancer Center.